Inhibition of airway remodeling in IL-5-deficient mice

Journal of Clinical Investigation

Volumn 113, Issue 4, 2004, Pages 551-560

  Cho, Jae Youn ^a   Miller, Marina ^a   Baek, Kwang Je ^a   Han, Ji Won ^a   Nayar, Jyothi ^a   Lee, Sook Young ^a   McElwain, Kirsti ^a   McElwain, Shauna ^a   Friedman, Stephanie ^a   Broide, David H ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 3; COLLAGEN TYPE 5; INTEGRIN; INTERLEUKIN 5; MAJOR BASIC PROTEIN; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA; ALPHAVBETA6 INTEGRIN; TUMOR ANTIGEN;

AIRWAY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FIBROSIS; IMMUNOHISTOCHEMISTRY; MOUSE; MUCUS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; THICKNESS; ANIMAL; CYTOLOGY; GENETICS; HISTOLOGY; HUMAN; IMMUNOLOGY; INHALATION TEST; LUNG FIBROSIS; LUNG LAVAGE; METABOLISM; MOUSE MUTANT; PATHOLOGY; RESPIRATORY SYSTEM; RESPIRATORY TRACT MUCOSA;

ANIMALS; ANTIGENS, NEOPLASM; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; HUMANS; INTEGRINS; INTERLEUKIN-5; MICE; MICE, KNOCKOUT; OVALBUMIN; PULMONARY FIBROSIS; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; TRANSFORMING GROWTH FACTOR BETA;

EID: 85047693288     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19133     Document Type: Article

References (34)

1. Rothenberg, M.E. 1998. Eosinophilia. N. Engl. J. Med. 338:1592-1600.
2. Broide, D. 2002. Fast flowing eosinophils: signals for stopping and stepping out of blood vessels. Am. J. Respir. Cell Mol. Biol. 26:637-640.
3. Lopez, A.F., et al. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
4. Foster, P.S., Hogan, S.P., Ramsay, A.J., Matthaei, K.I., and Young, I.G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
5. Lee, J.J., et al. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185:2143-2156.
6. Hamelmann, E., et al. 1997. Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819-825.
7. Hamelmann, E., et al. 1999. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 160:934-941.
8. Corry, D, et al. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
9. Shen, H.H., et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170:3296-3305.
10. Mattes, J., et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195:1433-1444.
11. Robinson, D.S., et al. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
12. Broide, D.H., Paine, M.M., and Firestein, G.S. 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414-1424.
13. Sur, S., Gleich, GJ., Swanson, M.C., Bartemes, K.R., and Broide, D.H. 1995. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J. Allergy Clin. Immunol. 96:661-668.
14. Shi, H.Z., et al. 1998. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am. J. Respir. Crit. Care Med. 157:204-209.
15. Leckie, M.J., et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 356:2144-2148.
16. Flood-Page, P.T., Menzies-Gow, A.N., Kay, A.B., and Robinson, D.S. 2003. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167:199-204.
17. Elias, J.A., Zhu, Z., Chupp, G., and Homer, R.J. 1999. Airway remodeling in asthma. J. Clin. Invest. 104:1001-1006.
18. Roche, W.R., Beasley, R., Williams, J., and Holgate, S.T. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1:520-524.
19. Johnson, P.R., et al. 2001. Airway smooth muscle cell proliferation is increased in asthma. Am. J. Resp. Crit. Care. Med. 164:474-477.
20. Ohno, I., et al. 1996. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 15:404-409.
21. Minshall, E.M., et al. 1997. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 7:326-333.
22. Elovic, A.E., et al. 1998. IL-4-dependent regulation of TGF-alpha and TGF-beta 1 expression in human eosinophils. J. Immunol. 160:6121-6127.
23. Ohkawara, Y., et al. 2000. Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am. J. Respir. Cell Mol. Biol. 23:444-451.
24. Ikeda, R.K., et al. 2003. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol. 171:4860-4867.
25. Ikeda, R.K., et al. 2003. Resolution of airway inflammation following OVA inhalation: comparison of ISS DNA and corticosteroids. Am. J. Resp. Cell Mol. Biol. 28:655-663.
26. Lee, C.G., et al. 2001. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194:809-821.
27. Blobe, G.C., Schiemann, W.P., and Lodish, H.F. 2000. Role of transforming growth factor beta in human disease. New. Engl. J. Med. 342:1350-1358.
28. Munger, J.S., et al. 1999. The integrin αVβ6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:319-328.
29. Huang, X.Z., et al. 1996. Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J. Cell Biol. 133:921-928
30. Breuss, J.M., et al. 1995. Expression of the β6 integrin subunit in development, neoplasia, and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 108:2241-2251.
31. Blyth, D.I., Wharton, T.F., Pedrick, M.S., Savage, T.J., and Sanjar, S. 2000. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am. J. Respir. Cell Mol. Biol. 23:241-246.
32. Foster, P.S., et al. 2000. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab. Invest. 80:655-662.
33. Phipps, S., et al. 2002. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J. Immunol. 169:4604-4612.
34. Flood-Page, P., et al. 2003. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 112:1029-1036. doi:10.1J72/JCI200317974.